Freenome, high-profile liquid biopsy company, quietly replaces its CEO

Freenome, a high-profile startup that aims to develop a blood test to detect colon cancer, has quietly replaced its co-founder and chief executive, Gabriel Otte.

The company’s chief business officer, Mike Nolan, a long-time veteran of the genomics and diagnostic industries, is Freenome’s new CEO. He was identified as such in a Freenome press release on Friday about new data on its experimental test; he is also listed as CEO on Freenome’s website and on his own LinkedIn profile.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Most Related Links :
Business News Governmental News Finance News

Need Your Help Today. Your $1 can change life.

[charitable_donation_form campaign_id=57167]

Source link

Back to top button